Banner 1 Banner 2 Banner 3 Banner 5 Banner 4

BioStem’s mission is to provide high technologist products and services to help diagnostic treating patients’ critical illness and improve quality of life through cutting-edge technologies. Our vision is to be the recognized performance leader to complete all customer needs for clinicians, small to large pharmaceutical companies or pure medical device companies.

Products & Services

Oncotype DX® tests

Oncotype DX® tests

The Oncotype DX® portfolio of breast, colon and prostate cancer tests applies advanced genomic science to reveal the unique biology of a tumor in order to optimize cancer treatment decisions, helping to guide treatment decisions for more than 1 million cancer patients worldwide. The Oncotype DX Breast Recurrence Score® assay is the only test that has been shown to predict the likelihood of chemotherapy. 
For further information, please go to oncotypeiq.com/en.
READ MORE

Integrative Pathology Tests

Integrative Pathology Tests

We provide a comprehensive range of functional health and wellbeing pathology testing. Assessments investigate in the fields of endocrine, gastrointestinal, immunological, genomic, metabolic, and nutritional balance. The result is accurate, reliable, and fast turnaround times. Thus, our practitioners can provide the best consultative process for the treatment of their patients.
READ MORE

Masuyama Test

Masuyama Test

In order to determine how well your body can defend itself against dangerous abnormal cells, Masuyama Test measures activity in a core part of your immune system: the Natural Killer cell.
READ MORE

Cancer Vaccine

Cancer Vaccine

Cancer vaccine,the choice of a new treatment Specific attack to cancer,“Dendritic cell vaccine therapy”
READ MORE

Jinsoo Ginseng

Jinsoo Ginseng

Black ginseng is made by Nine (9) times steaming and drying. A noticeable superiority for black ginseng over white and red ginseng in most of the comparative biological studies including anticarcinogenic, immunomodulatory, anti-Inflammatory, antidiabetic, hepatoprotective, antioxidant and improving blood circulation.
READ MORE

Hydrafacial

Hydrafacial

Only HydraFacial uses patented technology to cleanse, extract, and hydrate. HydraFacial super serums are made with nourishing ingredients that create an instantly gratifying glow in just 3 steps: Cleanse+Peel, Extract+Hydrate, Fuse+Protect.
READ MORE

PRODUCT HILIGHT

NEW VIDEO

  • Oncotype DX Breast Recurrence Score
  • PATIENT STORIES
Oncotype DX Breast Recurrence Score
The Value of Oncotype DX Test in Early-Stage Breast Cancer
Dr. Jeremy Force, Dr. Virgina Kaklamani, and Dr. Anthony Lucci speak on the information Oncotype ...
Why the Oncotype DX Breast Recurrence Score test
Dr. Jeremy Force, Dr. Virgina Kaklamani, and Dr. Anthony Lucci speak why they use Oncotype DX? te...
How the Oncotype DX Recurrence Score Result Makes a Difference in Treatment Decisions?
At the 2013 San Antonio Breast Cancer Symposium: Dr. Jay K. Harness, Medical Director at BreastC...
Kevin Kalinsky, MD, shares impressions of the RxPONDER clinical trial presented at SABCS 2020
Dr. Kalinsky, Director, Glenn Family Breast Center, Winship Cancer Institute, Emory University, s...
Dr. Julie R. Gralow Discusses Findings from the RxPONDER Study Released at SABCS 2020
A groundbreaking, BCRF-supported phase III clinical trial, RxPONDER, has just demonstrated that s...
Put Chemo to the Test -- Hear from Breast Cancer Patients
Do you really need chemotherapy for your early-stage breast cancer? The Oncotype DX? test is the ...
DCIS (Stage 0) Breast Cancer and the Oncotype DX? Breast DCIS Score?
Not all DCIS patients will benefit from the addition of radiation therapy to their treatment. Gen...
Comparison between Oncotype DX? Assay and MammaPrint? Assay
Poulet et al. Risk Classification of Early Stage Breast Cancer as Assessed by MammaPrint and Onco...
Ask for Answers: Will Chemotherapy Benefit Your Breast Cancer?
Only 4 of 100 women with early-stage invasive breast cancer benefit from chemotherapy*, and its t...
The Oncotype DX Test - 10 Years and Beyond
Over the past decade, Genomic Health has redefined personalized medicine through the innovation o...
Genomic Health & Oncotype DX - About Us
Genomic Health created the Oncotype DX cancer diagnosis test to help patients and doctors form a ...
Learn About the Oncotype DX Prostate Cancer Test
Using Oncotype DX to identify aggressive prostate cancer. Take the time to make your treatment de...
How Does the Oncotype DX Test Provide Insight Beyond Traditional Measures?
Breast cancer tumors are looked at like never before with the Genomic Health Oncotype DX Breast C...
Reasons For Breast Cancer Oncotype DX Test
Dr. Steven Shak, Chief Medical Officer for Genomic Health, tells us why all breast cancer patient...
Dr. Lavery: Not All Stage II Colon Cancer Patients Need Same Treatment
The Oncotype DX Colon Cancer Assay from Genomic Health is discussed by Dr. Ian Lavery, in which h...
About the Oncotype DX Test
Breast cancer and colon cancer patients develop individualized courses of treatment with Genomic ...
PATIENT STORIES
Oncotype DX DCIS Breast Cancer Score: Amys Story
Amy, a breast cancer survivor, describes her experience using Genomic Healths Oncotype DX DCIS Br...
Pass It On, Until Every Woman Knows About Personalized Breast Cancer Treatment Planning
Women with breast cancer can use the Genomic Health Oncotype DX Breast Cancer Assay to get person...
Oncotype DX Breast Cancer Patient Stories
Women with breast cancer talk about how the Oncotype DX Breast Cancer Assay from Genomic Health h...
Oncotype DX Patient Stories
Cancer survivors - Anne Marie, Dan and Monica - share their experiences with Oncotype DX, and how...
An Oncotype DX Colon Cancer Story
The Oncotype DX from Genomic Health is a test that helps assess recurrence risk for colon cancer ...
An Oncotype DX Breast Cancer Treatment Story from Mexico
The Oncotype DX Breast Cancer Assay was used by Monica, a mother and health administrator from Me...
Using the Oncoytpe DX Breast Cancer Test to Personalizing Treatment
Personalized breast cancer treatment with the Oncotype DX Breast Cancer Assay is explored by Dr. ...